Auro Laboratories Ltd
Auro Labs. | 530233
Share Price Chart - Auro Laboratories Ltd
Stock Performance
Ratios
Consolidated data not available
Please try selecting a different data type
About Company
- Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API)
- Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL
- It is the first-line treatment for type 2 diabetes
- The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra
- The facility has all the required certifications from Indian authorities and European registration organization
- Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards
- Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA
- The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments
- Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment
- Additionally, it also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
No Information Available
Growth Rate information is not available at this time.
All figures in ₹ Crores
No Information Available
No profit & lossdata available
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Auro Laboratories Ltd?
The current share price of Auro Laboratories Ltd (Auro Labs.) is ₹248.80. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Auro Laboratories Ltd?
The Price-to-Earnings (P/E) ratio of Auro Laboratories Ltd is 248.80. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Auro Laboratories Ltd?
Auro Laboratories Ltd has a 52-week high of ₹317.00 and a 52-week low of ₹159.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Auro Laboratories Ltd?
Auro Laboratories Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Auro Laboratories Ltd?
The Earnings Per Share (EPS) of Auro Laboratories Ltd is ₹2.95. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Auro Laboratories Ltd?
Auro Laboratories Ltd has a Return on Equity (ROE) of 4.33%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
